SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (14553)2/10/1998 10:55:00 PM
From: Hippieslayer  Read Replies (1) | Respond to of 32384
 
The street will have to determine if news about a disease that affects the very few is important enought to hoot and holler about. If they see that KS is just a gateway to allow Panretin to treat other type of cancers, then I think they'll go crazy. I hope I'm wrong, but I don't know just how well the street will react to this---a point or two rise will be the indication that the street did like the news. Anything above 2 points and then we know the water is boiling over and it's partay time!



To: Henry Niman who wrote (14553)2/10/1998 10:56:00 PM
From: Machaon  Read Replies (2) | Respond to of 32384
 
Henry, the article implied that Panretin could be an alternative to Chemotherapy. That sounds like a very large market.

What does this do to the earnings estimates out past the year 2000?

Regards, Bob